表紙
市場調查報告書

骨骼代謝化驗:體外診斷市場分析·預測模式

Bone Metabolism Assays - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 640278
出版日期 內容資訊 英文 40 Pages
訂單完成後即時交付
價格
Back to Top
骨骼代謝化驗:體外診斷市場分析·預測模式 Bone Metabolism Assays - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年11月01日內容資訊: 英文 40 Pages
簡介

本報告提供全球主要39個國家的骨骼代謝化驗市場調查,提供市場及產品概要,主要產業趨勢,檢查數量,用戶數,新銷售數,平均銷售價格等各種資料及其轉變,彙整檢驗各種類的年度收益變化與預測,競爭環境與企業佔有率,分析師的各種分析等彙整資料。

主要的調查內容

  • 目前正發售的產品·競爭趨勢
  • 主要產業趨勢的檢討
  • 年度收益的轉變·預測:各種區分
    • 抑鈣素檢驗
    • 副甲狀腺素檢驗
    • 膠原蛋白羧基縮氨酸檢驗
    • 1,25羥基維生素D檢驗
    • 25羥維生素D檢驗
  • 各種詳細資料
    • 整體檢查數量
    • 用戶數
    • 新銷售數
    • 平均銷售價格等
  • 企業佔有率
  • 分析師分析

本報告書的優點

  • 通過審查開發平台產品和技術,並通過識別具有最強大開發平台的公司來開發和設計您的對外授權策略。
  • 透過了解塑造和推動關節鏡市場的趨勢,來制定業務戰略。
  • 通過了解未來主要趨勢,創新產品和技術,市場分類,有影響力的企業等,來推動收入增長。
  • 通過了解競爭格局並分析市場領導者的公司佔有率,來制定有效的銷售和營銷策略。
  • 識別具有潛在強大產品組合的新興企業,並製定有效的反制策略以獲得競爭優勢。
  • 可追踪·預測2005 - 2024年全球·各國設備銷售情況
  • 鎖定可為合併,投資和戰略合作關係提供最大機會的市場類別和細分市場,組織您的銷售和營銷工作。

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0811EPD

GlobalData's Medical Devices sector report, "Bone Metabolism Assays - Medical Devices Pipeline Assessment, 2019" provides an overview of Bone Metabolism Assays currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Metabolism Assays pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Bone Metabolism Assays under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bone Metabolism Assays and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bone Metabolism Assays under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables 3
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 Bone Metabolism Assays Overview 5

3 Products under Development 6

  • 3.1 Bone Metabolism Assays - Pipeline Products by Stage of Development 6
  • 3.2 Bone Metabolism Assays - Pipeline Products by Segment 7
  • 3.3 Bone Metabolism Assays - Pipeline Products by Territory 8
  • 3.4 Bone Metabolism Assays - Pipeline Products by Regulatory Path 9
  • 3.5 Bone Metabolism Assays - Pipeline Products by Estimated Approval Date 10

4 Bone Metabolism Assays - Pipeline Products under Development by Companies 11

  • 4.1 Bone Metabolism Assays Companies - Pipeline Products by Stage of Development 11
  • 4.2 Bone Metabolism Assays - Pipeline Products by Stage of Development 12

5 Bone Metabolism Assays Companies and Product Overview 13

  • 5.1 Alere Inc Company Overview 13
    • 5.1.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 13
  • 5.2 AMS Diagnostics LLC Company Overview 14
    • 5.2.1 AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.3 Beckman Coulter Inc Company Overview 16
    • 5.3.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.4 Carolina Liquid Chemistries Corp Company Overview 17
    • 5.4.1 Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.5 DiaSorin SpA Company Overview 19
    • 5.5.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.6 Immunodiagnostic Systems Holdings plc Company Overview 22
    • 5.6.1 Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.7 Novartis AG Company Overview 23
    • 5.7.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.8 OJ-Bio Ltd (Inactive) Company Overview 24
    • 5.8.1 OJ-Bio Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.9 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 25
    • 5.9.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.10 Siemens Healthineers AG Company Overview 30
    • 5.10.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.11 Tosoh Bioscience Inc Company Overview 33
    • 5.11.1 Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 33

6 Bone Metabolism Assays- Recent Developments 34

  • 6.1 Mar 07, 2019: Mindray signs patient safety movement's open data pledge & becomes 90th company to join to improve patient safety 34
  • 6.2 Dec 04, 2018: Mindray international exchange program on hematology: linking medical expertise across borders 34

7 Appendix 37

  • 7.1 Methodology 37
  • 7.2 About GlobalData 40
  • 7.3 Contact Us 40
  • 7.4 Disclaimer 40

List of Tables

  • Table 1: Bone Metabolism Assays - Pipeline Products by Stage of Development 6
  • Table 2: Bone Metabolism Assays - Pipeline Products by Segment 7
  • Table 3: Bone Metabolism Assays - Pipeline Products by Territory 8
  • Table 4: Bone Metabolism Assay

List of Figures

  • Figure 1: Bone Metabolism Assays - Pipeline Products by Stage of Development 6
  • Figure 2: Bone Metabolism Assays - Pipeline Products by Segment 7
  • Figure 3: Bone Metabolism Assays - Pipeline Products by Territory 8
  • Figure 4: Bone Metabolism
Back to Top